Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Income Before Tax

-$37.39M

TTM · Period ending: · USD

LCTX logo

LCTX Income Before Tax

Latest reported-$37.39M
LCTX TTM Pre-Tax Income ($0.00 → -$37.39M)
High-resolution chart · PNG

LCTX income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
4,049,944
4,049,944
4,049,944
0
0
0
0
-1,100,000
-1,700,000
-2,800,000
-3,500,000
-3,400,000
-3,900,000
-2,800,000
-2,100,000
-1,100,000
0
0
0
0
0
0
-500,000
-800,000
-1,300,000
-1,300,000
-800,000
-500,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.